ArticleInvestigative ophthalmology & visual science2021

Targeting Plasma Kallikrein With a Novel Bicyclic Peptide Inhibitor (THR-149) Reduces Retinal Thickening in a Diabetic Rat Model.

Tine Van Bergen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.